Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> D >> 3,6-Dihydro-4-[[(trifluoromethyl)sulfonyl]oxy]-1(2H)-pyridinecarboxylic acid tert-butyl ester

3,6-Dihydro-4-[[(trifluoromethyl)sulfonyl]oxy]-1(2H)-pyridinecarboxylic acid tert-butyl ester
[CAS# 138647-49-1]

List of Suppliers
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Chemical manufacturer
chemBlink standard supplier since 2010
Cangzhou Enke Pharma-tech Co., Ltd. China Inquire  
+86 (317) 510-5699
510-6597
+86 15533709196
sale@enkepharma.com
enkepharma@126.com
Skype Chat
QQ chat
WeChat: ymzhao
Chemical manufacturer since 2011
chemBlink standard supplier since 2016
Maybridge Chemical Co., Ltd. Belgium Inquire  
+32 (14) 593-434
maybridge.sales@thermofisher.com
Chemical manufacturer
Complete supplier list of 3,6-Dihydro-4-[[(trifluoromethyl)sulfonyl]oxy]-1(2H)-pyridinecarboxylic acid tert-butyl ester
Identification
Name 3,6-Dihydro-4-[[(trifluoromethyl)sulfonyl]oxy]-1(2H)-pyridinecarboxylic acid tert-butyl ester
Synonyms 1-(tert-Butoxycarbonyl)-1,2,3,6-tetrahydropyridin-4-yl trifluoromethanesulfonate
Molecular Structure CAS # 138647-49-1, 3,6-Dihydro-4-[[(trifluoromethyl)sulfonyl]oxy]-1(2H)-pyridinecarboxylic acid tert-butyl ester, 1-(tert-Butoxycarbonyl)-1,2,3,6-tetrahydropyridin-4-yl trifluoromethanesulfonate
Molecular Formula C11H16F3NO5S
Molecular Weight 331.31
CAS Registry Number 138647-49-1
EC Number 689-280-9
Safety Data
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Acute toxicityAcute Tox.4H302
Acute toxicityAcute Tox.4H312
Acute toxicityAcute Tox.4H332
Skin irritationSkin Irrit.2H315
Specific target organ toxicity - single exposureSTOT SE3H335
Eye irritationEye Irrit.2AH319
Eye irritationEye Irrit.2H319
SDS Available
Market Analysis Reports
List of Reports Available for 3,6-Dihydro-4-[[(trifluoromethyl)sulfonyl]oxy]-1(2H)-pyridinecarboxylic acid tert-butyl ester
Related Products
2,3-Dihydro-6-(trifluoromethoxy)-1H-indole  2,3-Dihydro-5-(trifluoromethoxy)-1H-indole  rel-5-[[(1R,1aS,6bR)-1a,6b-Dihydro-1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-cyclopropa[b]benzofuran-5-yl]oxy]-3,4-dihydro-1,8-naphthyridin-2(1H)-one  3,4-Dihydro-7-(trifluoromethyl)-2H-1-benzopyran-4-acetic acid  3,4-Dihydro-8-(trifluoromethyl)-2H-1-benzopyran-4-amine  2,3-Dihydro-5-(trifluoromethyl)-1H-inden-1-ol  4,5-Dihydro-2-[3-(trifluoromethyl)phenyl]oxazole  2,3-Dihydro-6-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine  2,3-Dihydro-8-(trifluoromethyl)pyrrolo[2,1-b]quinazolin-9(1H)-one  2,3-Dihydro-5-(trifluoromethyl)spiro[1H-indene-1,2'-pyrrolidine  N-[(1R)-3-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]-L-aspartic acid  (3R)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-[[(1R)-1-phenylethyl]amino]-4-(2,4,5-trifluorophenyl)-1-butanone  (2Z)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-[[(1R)-1-phenylethyl]amino]-4-(2,4,5-trifluorophenyl)-2-buten-1-one  (3E)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-3-buten-1-one  1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-3-buten-1-one  (2E)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one  3,6-Dihydro-3'-(trifluoromethyl)-N-[4-[(trifluoromethyl)sulfonyl]phenyl][1(2H),2'-bipyridine]-4-carboxamide  Dihydro-5-[(3,4,5-trihydroxyphenyl)methyl]-2(3H)-furanone  4,5-Dihydro-1,2,3-trimethoxy-6H-dibenzo[de,g]quinoline-6-carboxaldehyde  1,3-Dihydro-3-[(2,4,6-trimethoxyphenyl)methylene]-2H-indol-2-one